Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 17:41:35 UTC |
---|
Update Date | 2022-11-23 22:29:18 UTC |
---|
HMDB ID | HMDB0257034 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Quinazolin-4-ylamine |
---|
Description | 3,4-dihydroquinazolin-4-imine belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Based on a literature review very few articles have been published on 3,4-dihydroquinazolin-4-imine. This compound has been identified in human blood as reported by (PMID: 31557052 ). Quinazolin-4-ylamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Quinazolin-4-ylamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | InChI=1S/C8H7N3/c9-8-6-3-1-2-4-7(6)10-5-11-8/h1-5H,(H2,9,10,11) |
---|
Synonyms | Value | Source |
---|
Quinazolin-4-amine | MeSH |
|
---|
Chemical Formula | C8H7N3 |
---|
Average Molecular Weight | 145.1613 |
---|
Monoisotopic Molecular Weight | 145.063997239 |
---|
IUPAC Name | 3,4-dihydroquinazolin-4-imine |
---|
Traditional Name | 3H-quinazolin-4-imine |
---|
CAS Registry Number | Not Available |
---|
SMILES | N=C1NC=NC2=CC=CC=C12 |
---|
InChI Identifier | InChI=1S/C8H7N3/c9-8-6-3-1-2-4-7(6)10-5-11-8/h1-5H,(H2,9,10,11) |
---|
InChI Key | DRYRBWIFRVMRPV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Quinazolinamines |
---|
Alternative Parents | |
---|
Substituents | - Quinazolinamine
- Aminopyrimidine
- Imidolactam
- Benzenoid
- Pyrimidine
- Heteroaromatic compound
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.88 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 8.7629 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.38 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 802.3 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 314.8 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 87.3 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 194.8 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 96.9 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 266.2 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 274.3 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 624.9 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 585.6 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 120.6 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 794.0 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 187.7 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 227.4 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 456.4 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 433.1 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 156.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
quinazolin-4-ylamine,1TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C=NC2=CC=CC=C12 | 1584.3 | Semi standard non polar | 33892256 | quinazolin-4-ylamine,1TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C=NC2=CC=CC=C12 | 1659.2 | Standard non polar | 33892256 | quinazolin-4-ylamine,1TMS,isomer #1 | C[Si](C)(C)N=C1[NH]C=NC2=CC=CC=C12 | 2433.3 | Standard polar | 33892256 | quinazolin-4-ylamine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=CC=CC=C2C1=N | 1747.6 | Semi standard non polar | 33892256 | quinazolin-4-ylamine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=CC=CC=C2C1=N | 1712.9 | Standard non polar | 33892256 | quinazolin-4-ylamine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=CC=CC=C2C1=N | 2526.3 | Standard polar | 33892256 | quinazolin-4-ylamine,2TMS,isomer #1 | C[Si](C)(C)N=C1C2=CC=CC=C2N=CN1[Si](C)(C)C | 1839.4 | Semi standard non polar | 33892256 | quinazolin-4-ylamine,2TMS,isomer #1 | C[Si](C)(C)N=C1C2=CC=CC=C2N=CN1[Si](C)(C)C | 1841.1 | Standard non polar | 33892256 | quinazolin-4-ylamine,2TMS,isomer #1 | C[Si](C)(C)N=C1C2=CC=CC=C2N=CN1[Si](C)(C)C | 2246.4 | Standard polar | 33892256 | quinazolin-4-ylamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C=NC2=CC=CC=C12 | 1856.1 | Semi standard non polar | 33892256 | quinazolin-4-ylamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C=NC2=CC=CC=C12 | 1835.1 | Standard non polar | 33892256 | quinazolin-4-ylamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1[NH]C=NC2=CC=CC=C12 | 2550.8 | Standard polar | 33892256 | quinazolin-4-ylamine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=CC=CC=C2C1=N | 1969.1 | Semi standard non polar | 33892256 | quinazolin-4-ylamine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=CC=CC=C2C1=N | 1908.0 | Standard non polar | 33892256 | quinazolin-4-ylamine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=CC=CC=C2C1=N | 2568.0 | Standard polar | 33892256 | quinazolin-4-ylamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1C2=CC=CC=C2N=CN1[Si](C)(C)C(C)(C)C | 2215.5 | Semi standard non polar | 33892256 | quinazolin-4-ylamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1C2=CC=CC=C2N=CN1[Si](C)(C)C(C)(C)C | 2248.2 | Standard non polar | 33892256 | quinazolin-4-ylamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C1C2=CC=CC=C2N=CN1[Si](C)(C)C(C)(C)C | 2430.7 | Standard polar | 33892256 |
|
---|